Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chamberlain, R. S.
Right arrow Articles by Blumgart, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chamberlain, R. S.
Right arrow Articles by Blumgart, L. H.

Annals of Surgical Oncology, Vol 7, Issue 1 55-66, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Hilar cholangiocarcinoma: a review and commentary

R. S. Chamberlain and L. H. Blumgart
Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.

Hilar cholangiocarcinoma is an uncommon cause of malignant biliary obstruction marked by local tumor spread for which surgery offers the only chance of cure. The diagnostic evaluation and surgical management of this disease continues to evolve. Although direct cholangiography and endoscopic biliary procedures have been used extensively to anatomically define the extent of tumor involvement, establish biliary decompression, and obtain histological confirmation of tumor, reliance on these invasive procedures is no longer necessary, and may be detrimental. Current noninvasive imaging technology permits accurate staging of the primary tumor and has improved patient selection for operative intervention without the need for invasive procedures. Overall survival has improved in accordance with an increasingly aggressive surgical approach. The propensity of this tumor for local invasion has led most experienced hepatobiliary centers to perform a partial hepatectomy in 50% to 100% of cases. Three-year survival rates of 35% to 50% can be achieved when negative histological margins are attained at the time of surgery. When resection is not feasible, either operative bilioenteric bypass or percutaneous transhepatic intubation can achieve significant palliation. There is no effective adjuvant therapy for this disease, and unless clear indications of unresectability exist, most patients should be considered for surgical exploration.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
J.-Y. Choi, M.-J. Kim, J. M. Lee, K. W. Kim, J. Y. Lee, J. K. Han, and B. I. Choi
Hilar Cholangiocarcinoma: Role of Preoperative Imaging with Sonography, MDCT, MRI, and Direct Cholangiography
Am. J. Roentgenol., November 1, 2008; 191(5): 1448 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. Hernandez, S. M. Cowgill, S. Al-Saadi, D. Villadolid, S. Ross, E. Kraemer, M. Shapiro, J. Mullinax, J. Cooper, S. Goldin, et al.
An Aggressive Approach to Extrahepatic Cholangiocarcinomas Is Warranted: Margin Status Does Not Impact Survival after Resection
Ann. Surg. Oncol., March 1, 2008; 15(3): 807 - 814.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
H. J. Kim, A. Y. Kim, S. S. Hong, M.-H. Kim, J. H. Byun, H. J. Won, Y. M. Shin, P. N. Kim, H. K. Ha, and M.-G. Lee
Biliary Ductal Evaluation of Hilar Cholangiocarcinoma: Three-dimensional Direct Multi-Detector Row CT Cholangiographic Findings versus Surgical and Pathologic Results--Feasibility Study
Radiology, December 1, 2005; 238(1): 300 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
B. I. Choi, J. K. Han, S. T. Hong, and K. H. Lee
Clonorchiasis and Cholangiocarcinoma: Etiologic Relationship and Imaging Diagnosis
Clin. Microbiol. Rev., July 1, 2004; 17(3): 540 - 552.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.